$28.40
+0.69 (+2.49%)
Performance
1D
—
1W
—
1M
—
3M
-0.32%
6M
+1.83%
1Y
-16.17%
YTD
+0.50%
Open$27.39
Previous Close$27.71
Day High$28.53
Day Low$27.31
52W High$36.32
52W Low$25.17
Volume—
Avg Volume1.54M
Market Cap5.32B
P/E Ratio15.68
EPS$2.03
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.02
Below
SMA 200
$29.87
Below
RSI (14)
32.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+345.1% upside
Current
$28.40
$28.40
Target
$126.40
$126.40
$90.34
$126.40 avg
$146.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.54B | 1.40B | 1.89B |
| Net Income | 363.64M | 297.82M | 267.01M |
| Profit Margin | 23.6% | 22.4% | 14.1% |
| EBITDA | 427.43M | 369.52M | 438.15M |
| Free Cash Flow | — | — | 233.31M |
| Rev Growth | +9.9% | +9.9% | +6.3% |
| Debt/Equity | — | — | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |